Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
Get the latest updates from "TAK-573 multiple myeloma" - Google News directly as they happen.
Follow now < 10 followers
Last updated about 2 years ago
about 2 years ago
Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD...
about 2 years ago
Modakafusp Alfa Elicits Single-Agent Activity, Represents a Novel Option in Relapsed/Refractory Myeloma...
over 2 years ago
Dr. Vogl on the Utilization of Modakafusp in Relapsed/Refractory Multiple Myeloma OncLive
over 2 years ago
Fierce Pharma Asia—Merck, Eisai's failed Lenvima trial; J&J, Legend's CAR-T data; AstraZeneca-Samsung...
over 2 years ago
Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology...
over 2 years ago
Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology...
over 2 years ago
Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology...
over 2 years ago
Applied BioMath, LLC Announces Participation at the American Conference on Pharmacometrics (ACoP12)...
over 2 years ago
Applied BioMath, LLC Announces Participation at the American Conference on Pharmacometrics (ACoP12)...
over 2 years ago
Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q2 2022 Results...
over 2 years ago
Go or go go? J&J’s cell therapy heads to the FDA Vantage
almost 3 years ago
Multiple Myeloma Pipeline Analysis Demonstrates Stunning Growth With A Gamut of Pharma...